focus -WSS

focus

author：focus 2025-10-01 21:47:39 - browse：6841

Abbott's heart device TriClip on a gradient dark blue background — coverage from STAT — The device is called the TriClip, and it addresses a disease called tricuspid regurgitation: a heart condition that causes blood to leak backward through the tricuspid heart valve. Illustration: STAT; Photo: Courtesy Abbott

An advisory panel to the Food and Drug Administration voted in favor of a new device from Abbott meant to treat patients with tricuspid heart valve disease. All but one of the 14 panelists said the treatment’s benefits outweighed its risks. The FDA tends to follow advisory panel recommendations.

“If we can help symptoms with this at a low cost in terms of risk, I think it makes a lot of sense,” said James Blankenship, a panelist and cardiologist at the University of New Mexico.

The device is called the TriClip, and it addresses a disease called tricuspid regurgitation: a heart condition that causes blood to leak backward through the tricuspid heart valve. The condition impacts 1.6 million people in the United States. Symptoms include fatigue, swelling, and atypical heart rhythms. In severe cases, the condition can lead to heart failure.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： FDA approves Sage Therapeutics’ rapid

explore

entertainment

WSS

How to ethically and practically extend health care to all

FDA scientists endorse Pfizer/BioNTech Covid

How I helped Pfizer think through the ethics of Viagra

Physicians aren't 'burning out.' They're suffering from moral injury

Medicare slashes safety net hospital payments by nearly $1 billion

Why Charlie Gard's case is so disturbing to Americans

leisure time

focus

explore

Anesthesiologist group: stop taking Ozempic before surgery

VC firm General Catalyst wants to buy a health system

Anesthesiologist group: stop taking Ozempic before surgery

Bill would stop addiction treatment from triggering child abuse inquiry

ChatGPT in medicine: STAT answers readers' burning questions

2 officers injured in shooting in Orlando, police say

Walensky prepares to leave CDC — and Congress — behind

Alnylam reports growth in sales of rare disease treatments

Heart attack and stroke risk calculators need revising

2 officers injured in shooting in Orlando, police say

hotspot

Liquid biopsy for lung cancer is launched by Delfi

FDA approves Sage Therapeutics’ rapid

Colorectal cancer study finds potential in overlooked immune cell

The future of health care in the House

Personalized medicine goes far beyond genetics

FDA approves Sage Therapeutics’ rapid

leisure time

explore

entertainment

hotspot